VHCP Management III, LLC Insider Trading -- Recent SEC Form 4 Transactions

VHCP Management III, LLC (CIK 1738053) reported 19 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-03-27). Recent activity: Sell KALV (21,386 shares), Sell KALV (160 shares), Sell KALV (174,485 shares), Sell KALV (15,417 shares), Sell KALV (3,183 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-03-27KalVista Pharmaceuticals, Inc. (KALV)InsiderSell21,386$379,815
2026-03-27KalVista Pharmaceuticals, Inc. (KALV)InsiderSell160$2,805
2026-03-27KalVista Pharmaceuticals, Inc. (KALV)InsiderSell174,485$3.0M
2026-03-27KalVista Pharmaceuticals, Inc. (KALV)InsiderSell15,417$290,148
2026-03-27KalVista Pharmaceuticals, Inc. (KALV)InsiderSell3,183$60,859
2025-04-11KalVista Pharmaceuticals, Inc. (KALV)InsiderBuy25,000$235,500
2025-02-27Oruka Therapeutics, Inc. (ORKA)InsiderBuy574$6,257
2025-02-27Oruka Therapeutics, Inc. (ORKA)InsiderBuy9,593$105,043
2025-02-27Oruka Therapeutics, Inc. (ORKA)InsiderBuy8,971$106,396
2025-02-27Oruka Therapeutics, Inc. (ORKA)InsiderBuy14,950$173,868
2025-02-27Oruka Therapeutics, Inc. (ORKA)InsiderBuy88,794$1.0M
2025-02-14KalVista Pharmaceuticals, Inc. (KALV)InsiderBuy100,000$923,000
2025-02-14KalVista Pharmaceuticals, Inc. (KALV)InsiderBuy61,700$575,661
2025-02-11KalVista Pharmaceuticals, Inc. (KALV)InsiderBuy73,649$684,199
2025-02-11KalVista Pharmaceuticals, Inc. (KALV)InsiderBuy4,137$37,812
2025-02-11KalVista Pharmaceuticals, Inc. (KALV)InsiderBuy26,703$245,134
2025-02-03KalVista Pharmaceuticals, Inc. (KALV)InsiderBuy43,707$382,873
2025-02-03KalVista Pharmaceuticals, Inc. (KALV)InsiderBuy11,754$104,493
2025-02-03KalVista Pharmaceuticals, Inc. (KALV)InsiderBuy14,562$134,262

Source: SEC Form 4 filings · as of 2026-03-27